Which has higher valuation and earnings, ELV or CNC?

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elevance Health $199.13B 0.45 $5.66B $22.50 18.51 Centene $194.78B 0.17 -$6.67B -$10.44 N/A

Does the media refer more to ELV or CNC?

In the previous week, Elevance Health had 5 more articles in the media than Centene. MarketBeat recorded 28 mentions for Elevance Health and 23 mentions for Centene. Elevance Health's average media sentiment score of 1.35 beat Centene's score of 0.90 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 21 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 11 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CNC or MOH?

In the previous week, Centene had 16 more articles in the media than Molina Healthcare. MarketBeat recorded 23 mentions for Centene and 7 mentions for Molina Healthcare. Centene's average media sentiment score of 0.90 beat Molina Healthcare's score of 0.74 indicating that Centene is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 11 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Molina Healthcare 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, CNC or HUM?

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Centene $194.78B 0.17 -$6.67B -$10.44 N/A Humana $129.66B 0.37 $1.19B $10.57 37.89

Is CNC or HUM more profitable?

Humana has a net margin of 0.88% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Centene -2.51% 12.12% 3.20% Humana 0.88% 11.20% 3.94%

Does the media prefer CNC or HUM?

In the previous week, Centene had 5 more articles in the media than Humana. MarketBeat recorded 23 mentions for Centene and 18 mentions for Humana. Humana's average media sentiment score of 1.13 beat Centene's score of 0.90 indicating that Humana is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 11 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Humana 11 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, OSCR or CNC?

Oscar Health has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oscar Health $11.70B 0.86 -$443.15M $1.40 23.24 Centene $194.78B 0.17 -$6.67B -$10.44 N/A

Is OSCR or CNC more profitable?

Oscar Health has a net margin of 3.60% compared to Centene's net margin of -2.51%. Oscar Health's return on equity of 38.45% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets Oscar Health 3.60% 38.45% 6.76% Centene -2.51% 12.12% 3.20%

Does the media favor OSCR or CNC?

In the previous week, Centene had 6 more articles in the media than Oscar Health. MarketBeat recorded 23 mentions for Centene and 17 mentions for Oscar Health. Centene's average media sentiment score of 0.90 beat Oscar Health's score of 0.54 indicating that Centene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oscar Health 9 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 11 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Is HQY or CNC more profitable?

HealthEquity has a net margin of 17.36% compared to Centene's net margin of -2.51%. HealthEquity's return on equity of 15.33% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.36% 15.33% 9.51% Centene -2.51% 12.12% 3.20%

Does the media favor HQY or CNC?

In the previous week, Centene had 14 more articles in the media than HealthEquity. MarketBeat recorded 23 mentions for Centene and 9 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.90 beat Centene's score of 0.90 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 11 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Centene (CNC) Competitors

$65.40 +1.34 (+2.09%)

Closing price 09/10/2026 03:59 PM Eastern

Extended Trading

$65.43 +0.03 (+0.05%)

As of 07:00 AM Eastern

Compare

CNC vs. ELV, MOH, HUM, OSCR, and HQY

Should you buy Centene stock or one of its competitors? Centene's main competitors and comparable companies include Elevance Health (ELV), Molina Healthcare (MOH), Humana (HUM), Oscar Health (OSCR), and HealthEquity (HQY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Centene compare to Elevance Health?

Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

In the previous week, Elevance Health had 5 more articles in the media than Centene. MarketBeat recorded 28 mentions for Elevance Health and 23 mentions for Centene. Elevance Health's average media sentiment score of 1.35 beat Centene's score of 0.90 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	21 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	11 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.45	$5.66B	$22.50	18.51
Centene	$194.78B	0.17	-$6.67B	-$10.44	N/A

Elevance Health currently has a consensus price target of $440.90, suggesting a potential upside of 5.84%. Centene has a consensus price target of $70.05, suggesting a potential upside of 7.12%. Given Centene's higher possible upside, analysts plainly believe Centene is more favorable than Elevance Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65
Centene	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.40

Elevance Health has a net margin of 2.47% compared to Centene's net margin of -2.51%. Elevance Health's return on equity of 14.64% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.47%	14.64%	5.22%
Centene	-2.51%	12.12%	3.20%

Elevance Health has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, Centene has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

Summary

Elevance Health beats Centene on 12 of the 17 factors compared between the two stocks.

How does Centene compare to Molina Healthcare?

Centene (NYSE:CNC) and Molina Healthcare (NYSE:MOH) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Centene has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market.

In the previous week, Centene had 16 more articles in the media than Molina Healthcare. MarketBeat recorded 23 mentions for Centene and 7 mentions for Molina Healthcare. Centene's average media sentiment score of 0.90 beat Molina Healthcare's score of 0.74 indicating that Centene is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	11 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Molina Healthcare	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Centene currently has a consensus price target of $70.05, suggesting a potential upside of 7.12%. Molina Healthcare has a consensus price target of $202.44, suggesting a potential upside of 0.97%. Given Centene's stronger consensus rating and higher possible upside, equities analysts plainly believe Centene is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.40
Molina Healthcare	2 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06

Molina Healthcare has lower revenue, but higher earnings than Centene. Molina Healthcare is trading at a lower price-to-earnings ratio than Centene, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$194.78B	0.17	-$6.67B	-$10.44	N/A
Molina Healthcare	$45.43B	0.23	$472M	-$0.18	N/A

93.6% of Centene shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 1.4% of Molina Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Molina Healthcare has a net margin of -0.02% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-2.51%	12.12%	3.20%
Molina Healthcare	-0.02%	3.73%	0.97%

Summary

Centene beats Molina Healthcare on 11 of the 17 factors compared between the two stocks.

How does Centene compare to Humana?

Centene (NYSE:CNC) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, Centene had 5 more articles in the media than Humana. MarketBeat recorded 23 mentions for Centene and 18 mentions for Humana. Humana's average media sentiment score of 1.13 beat Centene's score of 0.90 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	11 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	11 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$194.78B	0.17	-$6.67B	-$10.44	N/A
Humana	$129.66B	0.37	$1.19B	$10.57	37.89

Centene has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market. Comparatively, Humana has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

Centene presently has a consensus price target of $70.05, indicating a potential upside of 7.12%. Humana has a consensus price target of $403.91, indicating a potential upside of 0.85%. Given Centene's higher possible upside, research analysts plainly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.40
Humana	1 Sell rating(s)	15 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.43

Humana has a net margin of 0.88% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-2.51%	12.12%	3.20%
Humana	0.88%	11.20%	3.94%

93.6% of Centene shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.4% of Centene shares are owned by insiders. Comparatively, 0.2% of Humana shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Humana beats Centene on 9 of the 17 factors compared between the two stocks.

How does Centene compare to Oscar Health?

Oscar Health (NYSE:OSCR) and Centene (NYSE:CNC) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

Oscar Health has a net margin of 3.60% compared to Centene's net margin of -2.51%. Oscar Health's return on equity of 38.45% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oscar Health	3.60%	38.45%	6.76%
Centene	-2.51%	12.12%	3.20%

In the previous week, Centene had 6 more articles in the media than Oscar Health. MarketBeat recorded 23 mentions for Centene and 17 mentions for Oscar Health. Centene's average media sentiment score of 0.90 beat Oscar Health's score of 0.54 indicating that Centene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oscar Health	9 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	11 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Oscar Health presently has a consensus price target of $26.22, indicating a potential downside of 19.40%. Centene has a consensus price target of $70.05, indicating a potential upside of 7.12%. Given Centene's higher probable upside, analysts plainly believe Centene is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oscar Health	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.42
Centene	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.40

Oscar Health has a beta of 2.37, indicating that its share price is 137% more volatile than the broader market. Comparatively, Centene has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market.

Oscar Health has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oscar Health	$11.70B	0.86	-$443.15M	$1.40	23.24
Centene	$194.78B	0.17	-$6.67B	-$10.44	N/A

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 22.6% of Oscar Health shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Oscar Health beats Centene on 10 of the 16 factors compared between the two stocks.

How does Centene compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Centene (NYSE:CNC) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

HealthEquity has a net margin of 17.36% compared to Centene's net margin of -2.51%. HealthEquity's return on equity of 15.33% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Centene	-2.51%	12.12%	3.20%

HealthEquity currently has a consensus target price of $111.87, indicating a potential upside of 18.31%. Centene has a consensus target price of $70.05, indicating a potential upside of 7.12%. Given HealthEquity's stronger consensus rating and higher probable upside, equities analysts clearly believe HealthEquity is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
Centene	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.40

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 0.4% of Centene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Centene had 14 more articles in the media than HealthEquity. MarketBeat recorded 23 mentions for Centene and 9 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.90 beat Centene's score of 0.90 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	11 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.95	$215.20M	$2.77	34.13
Centene	$194.78B	0.17	-$6.67B	-$10.44	N/A

HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market. Comparatively, Centene has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

Summary

HealthEquity beats Centene on 13 of the 16 factors compared between the two stocks.

Get Centene News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNC vs. The Competition

Export

Metric	Centene	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$31.65B	$9.91B	$7.21B	$23.36B
Dividend Yield	N/A	2.60%	2.56%	3.78%
P/E Ratio	-6.26	33.79	272.84	28.46
Price / Sales	0.17	5.03	625.41	20.61
Price / Cash	13.67	125.92	77.33	34.40
Price / Book	1.60	5.29	10.41	4.70
Net Income	-$6.67B	$313.25M	$3.49B	$1.07B
7 Day Performance	-2.28%	-1.37%	-3.16%	-2.42%
1 Month Performance	0.78%	-0.88%	0.02%	-2.95%
1 Year Performance	91.50%	13.48%	17.33%	8.84%

Centene Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNC Centene	3.5344 of 5 stars	$65.40 +2.1%	$70.05 +7.1%	+109.0%	$31.65B	$194.78B	N/A	61,100	Trending News
ELV Elevance Health	4.3809 of 5 stars	$392.81 -0.4%	$440.90 +12.2%	+35.7%	$85.19B	$199.13B	17.46	97,100	Positive News Gap Up
MOH Molina Healthcare	1.4518 of 5 stars	$198.43 -0.8%	$202.44 +2.0%	+12.0%	$10.36B	$44.52B	N/A	19,000
HUM Humana	4.2633 of 5 stars	$384.25 -0.3%	$403.91 +5.1%	+46.5%	$46.14B	$129.66B	36.35	67,060	Positive News
OSCR Oscar Health	4.0333 of 5 stars	$30.00 -1.5%	$26.22 -12.6%	+67.2%	$9.26B	$11.70B	21.43	2,305	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNC) was last updated on 9/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Centene (CNC) Competitors

CNC vs. ELV, MOH, HUM, OSCR, and HQY

How does Centene compare to Elevance Health?

Summary

How does Centene compare to Molina Healthcare?

Summary

How does Centene compare to Humana?

Summary

How does Centene compare to Oscar Health?

Summary

How does Centene compare to HealthEquity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNC vs. The Competition

Centene Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Centene (CNC) Competitors

CNC vs. ELV, MOH, HUM, OSCR, and HQY

How does Centene compare to Elevance Health?

Does the media refer more to ELV or CNC?

Do insiders & institutionals hold more shares of ELV or CNC?

Which has higher valuation and earnings, ELV or CNC?

Do analysts rate ELV or CNC?

Is ELV or CNC more profitable?

Which has more volatility and risk, ELV or CNC?

Summary

How does Centene compare to Molina Healthcare?

Which has more volatility & risk, CNC or MOH?

Does the media prefer CNC or MOH?

Do analysts rate CNC or MOH?

Which has stronger valuation and earnings, CNC or MOH?

Do insiders and institutionals hold more shares of CNC or MOH?

Is CNC or MOH more profitable?

Summary

How does Centene compare to Humana?

Does the media prefer CNC or HUM?

Which has higher valuation and earnings, CNC or HUM?

Which has more volatility and risk, CNC or HUM?

Do analysts rate CNC or HUM?

Is CNC or HUM more profitable?

Do insiders & institutionals believe in CNC or HUM?

Summary

How does Centene compare to Oscar Health?

Is OSCR or CNC more profitable?

Does the media favor OSCR or CNC?

Do analysts rate OSCR or CNC?

Which has more risk and volatility, OSCR or CNC?

Which has stronger valuation & earnings, OSCR or CNC?

Do institutionals & insiders believe in OSCR or CNC?

Summary

How does Centene compare to HealthEquity?

Is HQY or CNC more profitable?

Do analysts rate HQY or CNC?

Do institutionals and insiders believe in HQY or CNC?

Does the media favor HQY or CNC?

Which has better earnings and valuation, HQY or CNC?

Which has more volatility and risk, HQY or CNC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNC vs. The Competition

Centene Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools